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Abstract
Background: We translated, modified, and extended a cognitive behavioral treatment (CBT)
protocol by Blanchard and Hickling (2003) for the purpose of treating survivors of MVA with full
or subsyndromal posttraumatic stress disorder (PTSD) whose native language is German. The
treatment manual included some additional elements, e. g. cognitive procedures, imaginal reliving,
and facilitating of posttraumatic growth. The current study was conducted in order to test the
efficacy of the modified manual by administering randomized controlled trial in which a CBT was
compared to a wait-list control condition.
Methods: Forty-two motor vehicle accident survivors with chronic or severe subsyndromal
posttraumatic stress disorder (PTSD) completed the treatment trial with two or three detailed
assessments (pre, post, and 3-month follow-up).
Results: CAPS-scores showed significantly greater improvement in the CBT condition as
compared to the wait list condition (group × time interaction effect size d = 1.61). Intent-to-treat
analysis supported the outcome (d = 1.34). Categorical diagnostic data indicated clinical recovery
of 67% (post-treatment) and 76% (3 months FU) in the treatment group. Additionally, patients of
the CBT condition showed significantly greater reductions in co-morbid major depression than the
control condition. At follow-up the improvements were stable in the active treatment condition.
Conclusion: The degree of improvement in our treatment group was comparable to that in
previously reported treatment trials of PTSD with cognitive behavioral therapy.
Trial registration: ISRCTN66456536
Background
Annually, more than 125.000 people are severely injured
and approximately 6000 die in motor vehicle accidents
(MVAs) in Germany [1]. Epidemiologic research in the
United States [2,3] and Germany [[4,5] Maercker, Perko-
nigg, Schmutzer & Brähler, submitted] has confirmed that
MVAs are among the most frequent traumatic events that
lead to Posttraumatic Stress Disorder (PTSD) in these
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vivors report PTSD prevalences ranging from about 2%
[6] to about 18% [7].
Prospective follow-up studies of injured MVA survivors
[summarized in [8]] showed that about 50% of initial
cases of PTSD remit within the first 6 months post-MVA.
Those who continue to be symptomatic beyond 6
months, and especially beyond 12 months, tend to have a
chronic course of the disorder with noticeable psychoso-
cial impact [9]. Thus, there is a need for treatment and
research on treatment for this population.
Recent meta-analyses and surveys have shown sufficient
effectiveness of psychotherapy for PTSD, and cognitive-
behavioral treatment in particular [10-13]. Much of this
research has either involved male combat veterans who
were 10–25 years post-trauma or female survivors of sex-
ual assault who were on average 5–10 years post-trauma.
Less research has been conducted with other homogenous
trauma-populations such as MVA survivors or survivors of
natural disasters. In a randomized controlled trial, Blan-
chard and associates demonstrated that a manualized CBT
program designed for MVA survivors who suffer from
PTSD or subsyndromal PTSD is superior to control condi-
tions (i.e. supportive therapy, wait list [14]). They also
demonstrated that the achieved PTSD symptom improve-
ments were stable for the CBT condition over two years
[14,15].
Cognitive behavioral treatment (CBT) for PTSD usually
includes exposure and cognitive restructuring procedures
[16]. Analyses showed that both procedures are highly
effective [10,11]. During the last decade, specifically elab-
orated cognitive procedures have been developed and
evaluated [17-20]. Recent PTSD treatment research
showed however that further treatment techniques
applied solely or embedded into new approaches are also
highly efficient. Among them are writing assignments
[20,21], facilitation of posttraumatic growth [22,23], or
social sharing [21]. One goal of the present study was to
combine well-established CBT techniques for PTSD treat-
ment (imaginal or in-vivo prolonged exposure and cogni-
tive restructuring) with additional procedures such as
writing assignments, social sharing, and facilitation of
posttraumatic growth. Based on Blanchard and Hickling's
[8] manual on standard CBT for posttraumatic stress in
MVA survivors, we developed an advanced CBT manual
[24] to include these treatment elements.
The present study was aimed to apply a translated and
extended version of this CBT program in German MVA
survivors and to test its efficacy and the stability of the
improvements 3 months after the treatment.
Methods
Experimental design and patient flow
Recruitment of patients was performed at the University
of Technology Dresden, Germany, from April 2002 to
August 2004. Treatment and 3-month follow-ups on all
participants were completed in February 2005. The proto-
col was approved by the local ethics board and all partici-
pants gave written informed consent. After the patients
have been recruited and completed the initial assessment,
they were matched into dyads based on the initial Clini-
cian Administered PTSD Scale (CAPS) score, diagnosis
(full vs. subsyndromal PTSD) and randomly assigned to
one of two conditions: (1) a combination of cognitive
behavioral treatment (CBT) procedures or (2) a Wait List
Control (WLC) condition. The latter was crossed over
after the post-assessment to the CBT condition.
Of 239 potential participants who were screened by tele-
phone, 132 were offered an appointment for assessment
and 110 completed the assessment. Eleven were excluded
on the basis of co-morbid diagnoses (1 with bipolar dis-
order, 5 with current alcohol or drug abuse or depend-
ence, and 2 with noticeable cognitive impairment
secondary to the MVA – as clinically observed by asses-
sors); 44 others were not included in the treatment study
because of too few symptoms or too low CAPS score.
Sixty-five patients were eligible for treatment and there-
fore offered treatment. Seventeen refused treatment due to
geographical distance. Forty-eight attended at least one
treatment session. Data from all of these were used in the
intent-to-treat analysis. There were six dropouts (2 from
CBT, 4 from Wait List). Thus, 42 participants completed
the post-treatment assessment.
Participants
Our sample included 22 individuals who met DSM-IV cri-
teria for PTSD and 20 individuals with severely sympto-
matic subsyndromal PTSD [meets criterion A, E and F for
PTSD and two of criteria B, C, or D [see [8] or [25] for a
description of the utility of this category] with a CAPS
score of 30 or higher. Demographic variables for the par-
ticipants in each of the treatment conditions, and for the
treatment drop-outs combined, are presented in Table 1.
The CBT and WLC conditions did not differ significantly
in any of the variables presented in Table 1 even though
there were more men in the wait list control than in the
CBT condition. The two dropouts from CBT condition did
not differ significantly from treatment completers on any
tabulated variable.
A reliability check on diagnosis of PTSD was made by hav-
ing a trained graduate student assessor, blind to diagnosis,
reassess half of the sample (n = 20) by listening to audio
tapes of the initial interview. Kappa for diagnostic agree-Page 2 of 8
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CAPS scores was r (n = 20) = 0.94, p < 0.001.
Therapists
In order to increase the external validity of the study by
working with a broad variety of therapists, six therapists (5
female, 1 male) were trained for the present CBT protocol.
All were already licensed psychotherapists or in their last
year of postgraduate psychotherapy education. They saw
participants in the university practice offices.
The first author and three other licensed and experienced
therapists supervised the therapists by regular meetings
with video tapes or tele-conferences. All therapy sessions
were video taped and scored for treatment adherence to
our CBT manual by graduate students. The correspond-
ence between raters and corresponding ideal protocols
was kappa = 0.63 (s.d. = 0.13, p < .05).
Measures
Postgraduate students in Clinical Psychology conducted
all assessments after the last author had extensively
trained each student. To the extent possible, a participant
was assessed by the same assessor at all assessments. By
instruction of each study participant the assessors were
kept blind to treatment condition.
Initial assessment
Participants gave a written informed consent at the initial
visit. At the initial assessment circumstances of the partic-
ipant's MVA were taken without going into detail (no
exposure to trauma was intended). The participant was
assessed using the Clinician-Administered PTSD Scale
(CAPS, German version [26]). The CAPS was scored both
for the month immediately following the MVA and for the
current time. The current CAPS generated two scores, both
a categorical diagnosis of either PTSD, subsyndromal
PTSD or non-PTSD, and a total score obtained by sum-
ming the ratings of frequency and severity of each of the
17 symptoms. The latter was our primary dependent vari-
able.
Next, all participants were assessed for the possible pres-
ence of other Axis I disorders through the use of the SCID-
I (German version: [27]).
Several questionnaires were also administered to assess
current state and provide data comparable to that
reported in other studies. These included Impact of Event
Scale-Revised (IES-R; German version: [28]), the Beck
Depression Inventory (BDI; German version: [29]), the
State-Trait Anxiety Inventory (STAI; German version:
[30]), and the Posttraumatic Cognitions Inventory (PTCI:
[31]; German version: [32]). Furthermore, self-perceived
posttraumatic growth was assessed which will be pub-
lished separately. Also, a psychophysiological assessment
was conducted which will be published elsewhere [e.g.,
[33]]. Participants were paid €15 for completing the ini-
tial assessment including the psychophysiological investi-
gation.
Post-treatment assessment
At the conclusion of treatment, participants were reas-
sessed. All of the questionnaires were repeated as was the
psychophysiological assessment. The CAPS was re-admin-
istered as the chief dependent measure and again scored
both categorically for diagnosis and for a total symptom
score. Participants were again paid an additional €15 for
completing this assessment.
Three-month follow-up assessment
All of the procedures used at the post-treatment assess-
ment, including the interviews, questionnaires and psy-
chophysiological assessment were repeated. Participants
were again paid €15 for completing this assessment.
Randomization and wait-list procedure
One of the principal investigators (A.K.) matched partici-
pants into dyads, based on age, total CAPS score and diag-
nosis (either PTSD or subsyndromal), and number of
comorbid diagnoses and then randomly assigned dyads
to conditions and to therapists according to a list of ran-
dom numbers previously assigned to each participant.
The wait-list control individuals were told that their treat-
ment would be delayed for 2–3 months and that they
would need to be reassessed after that interval before
beginning their treatment. After the post-treatment assess-
ment, they were all given the CBT if they were still inter-
ested in treatment.
Table 1: Demographic information on patient completer groups 
and dropouts
Variable Condition
CBT N = 21 Wait List N = 21
Gender (M/F) 2/19 8/13
Age
M 39.4 41.3
SD 11.4 10.8
Average years of education
M 12.8 13.2
SD 2.5 2.8
Months since MVA
M 63.1 49.1
SD 75.2 52.9
Continuing medical treatment after MVA in days:
in-patient: M 18.1 24.9
out-patient: M 225.1 265.1Page 3 of 8
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In an effort to enhance the external validity, the treatment
allowed the therapist a range of 8–12 weekly sessions with
an expected mode of 10. Thus, the therapist could end
treatment after 8 visits if in his/her judgment maximum
benefit had been obtained; on the other hand treatment
could be extended up to 12 visits if the therapist believed
the extra sessions were necessary. Mean number of visits
for CBT was 11.4 (s.d. = 3.2).
The CBT condition combined several behavioral and cog-
nitive procedures which had been manualized [24]. The
initial visit consisted of a detailed description of PTSD and
its symptoms and discussion of how the specific patient's
symptoms fitted the description. Emphasis was placed on
helping the patient to understand PTSD as a reaction to
trauma, or "to normalize" the patient's view of his/her
symptoms. A description of the treatment components
was given. Lastly, the patients were asked to write a very
detailed description of the MVA and its immediate after-
math, including their thoughts and sensory perceptions,
and bring it to the next session.
Three kinds of exposure were emphasized. First was the
reading aloud of his/her description of the MVA by the
participant. This was done after the second session. Addi-
tionally, patients were asked to read it aloud repeatedly
(up to three times) at home and record their 'subjective
units of distress' (SUDs). This was tapered to once per day
when the patient complained of boredom in the task. This
procedure was designed to force the participant to learn to
reduce cognitive avoidance.
The second form of exposure was in sensu exposure. It fol-
lowed the standard procedure for prolonged imaginal
exposure described by [16]) and consisted of in-sensu
imagination of worst moment(s) of the traumatic event.
The therapists encouraged the patient to stay with the
memory until habituation leads to reduction of subjec-
tively experienced distress. Sequences of this imagination
are repeated until the patient reaches stable levels of low-
ered or disappeared stress.
The third form of exposure was in vivo exposure to fear
arousing cues related to traveling by automobile. An indi-
vidual hierarchy of tasks was constructed with the patient
and travel tasks assigned for each week beginning in Week
3. It could range from sitting behind the wheel of the car,
starting it, and backing out of the driveway, in very avoid-
ant cases, to driving near the MVA site or under conditions
vaguely related to travel conditions at the time of the
MVA. Gentle pressure was exerted to have the patient
accomplish more each week. In addition, they were urged
to use the newly learned relaxation skills to counter the
arousal caused by working on travel hierarchy items.
Involvement of spouse/significant other for these exer-
cises was encouraged.
Cognitive procedures concerned four domains. First, basic
cognitive restructuring [34] comprised instructions to the
patients to monitor their thoughts and feelings associated
with the accident-related negative emotional states.
Patients were taught to identify cognitive fallacies and
learned how to dispute them. In addition, they were
taught to identify negative self-talk and how to correct it
with positive coping self-talk.
Second, specific accident-related cognitions as described
in the Ehlers and Clark model [35] of cognitive treatment
of PTSD were identified and questioned, e.g., themes of
safety ("I will never feel safe again"), over-generalisation
of danger ("Traffic is never safe"), and memory distur-
bances ("I am loosing my mind because of what hap-
pened").
Third, special emphasis was given to identify subjective
guilt and anger feelings. In case of predominating feelings
of guilt or anger somewhat extended cognitive modules
were applied to address and dispute these feelings [35].
Advanced cognitive dispute procedures or behavioral
experiments were introduced, e.g. "Anger chair" or "Guilt
letter" assignments [24].
Fourth, attention was paid to existential issues such as the
recurring thought that the patient could have died in the
accident and if and how one could regard oneself as posi-
tively changed or personally grown by overcoming the
traumatic experience and its aftermath [23]. When
patients mentioned positive changes as a result of coping
with the trauma, the reported benefits were appreciated
and attributed as the patients' personal successes. In addi-
tion, the repeated completion of a questionnaire on post-
traumatic growth [36] provided further occasions for
discussing this issue.
Results
Initial treatment outcome
The primary analysis in this study is the comparison of
CAPS scores for the two conditions from pre-treatment to
post-treatment. The relevant mean scores are in Table 2
along with the means for the CBT condition available for
the 3-month follow-up.
A repeated measures ANOVA (Group × Time) revealed a
significant main effect of Time (F [1, 40] = 63.79, p <
0.001, Cohen's d = 2.53) and a significant interaction of
Group × Time (F [1, 40] = 25.81, p < 0.001, d = 1.61) but
no main effect of Group. A between group comparison at
post-test by ANCOVA (controlled for pre-values) revealed
that the CBT condition showed greater PTSD symptomPage 4 of 8
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1.55).
The intent-to-treat analysis including data from drop-outs
revealed similar results, a main significant effect of Time
(F [1, 42] = 51.0, p < 0.001, d = 2.20) and a significant
interaction of Group × Time (F [1, 42] = 18.9, p < 0.001,
d = 1.34). For controlling the gender imbalance of the two
groups a repeated measures ANOVA (Group × Time) was
performed only for women (19 in CBT and 13 in WLC)
and revealed an even higher significant main effect of
Time (F [1, 30] = 83.02, p < 0.001, Cohen's d = 3.33) and
a significant interaction of Group × Time (F [1, 30] =
33.69, p < 0.001, d = 2.12) but no main effect of Group.
A second way to view these data is in terms of the categor-
ical variable of whether participants changed diagnostic
category or improved from PTSD/subsyndromal PTSD to
non-PTSD. This could also be seen as a measure of clini-
cally significant change. The categorical diagnostic data
from before to after treatment are shown in Table 3.
These data were analyzed with a 2 × 2 chi square test com-
paring status of full recovery (non-PTSD) in the CBT or
control condition. It revealed that CBT was superior to
Wait List (Chi2 [1, N = 21] = 3.70, p < 0.05) post-treat-
ment. Thus, in summary 67% of those with initial PTSD
or sub-PTSD treated by CBT had improved, compared to
19% of those on the Wait List who were assessed twice.
Our assessments allowed us to examine possible changes
in co-morbid major depressive disorder (MDD). It should
be remembered that this co-morbid condition was not
explicitly targeted by the treatment. Results for MDD
were: Seven patients from CBT condition had MDD prior
to treatment, all recovered from MDD at post-treatment.
Three patients from WLC condition had MDD prior, 2
cases remained depressed by the post-treatment assess-
ment. Chi squares test revealed, for those with MDD
(49% of the sample), that CBT led to a significantly higher
rate of recovery than Wait List (Chi2 [1, N = 21] = 5.74, p
< 0.05). Moreover, none of the participants in the CBT
condition who were not depressed initially became
depressed during treatment.
Psychological questionnaires
Table 4 lists the pre-treatment and post-treatment values
for each of the psychological tests (in the interest of brev-
ity the 3-month follow-up values for the CBT participants
are also listed). Also in the table there are (a) results for
the Group × Time interaction from the Group × Time
repeated measures MANOVA and (b) whether the within
group change is significant from pre-treatment to post-
treatment (and from post-treatment to 3-month follow-
up).
Examining the results in Table 4 one finds significant (all
p < 0.01) change for those receiving CBT on measures of
intrusive and avoidance symptoms, depressive symptoms
(BDI), and posttraumatic cognitions (PTCI) from pre-
treatment to post-treatment with no additional change in
follow-up. Those in the Wait List condition did not signif-
icantly change on any measure. Between group compari-
sons at post-test by ANCOVAs (last column of table 4)
revealed that the CBT condition showed greater change
than WLC (all p < 0.01).
Three-month follow-up outcome
For the 3-month follow-up, data of only n = 17 partici-
pants were available due to logistic problems of the
research project. A series of repeated measure MANOVAs
showed stability of measured psychopathology (see
superscripts in table 4).
Table 2 already showed the mean CAPS scores at follow-
up. Because of the lack of untreated control condition
only tests of stability of treatment success in the CBT con-
dition are available (paired t-testpost/FU(16) = 0.7, p = 0.52).
From post-treatment to follow-up, the recovery rate (i.e.
rate of non-PTSD, see table 3) increased slightly from 67%
to 76% of the initial CBT group.
Discussion
This is the first German RCT utilizing a manualized CBT
program for MVA survivors with PTSD. A combination of
standard [8] and advanced cognitive-behavioral treatment
(CBT) procedures led to significantly greater reductions
on our chief dependent variable, the CAPS, in the CBT
condition as compared to a Wait List control condition.
Similar results were found for the categorical variable of
whether participants continued to meet the symptomatic
criteria for PTSD or not. When a more conservative re-
analysis including drop-outs was performed, CBT
remained superior to the Wait List.
Table 2: Pre-treatment and post-treatment CAPS scores on all 
groups and 3-months follow-up CAPS scores on treated groups
Group Time
Pre-Tx Post-Tx 3-months FU1
CBT
M 47.6 18.3 18.9
SD 19.1 18.8 23.8
Wait List
M 41.8 35.2 -
SD 17.1 23.0 -
1reduced N = 17Page 5 of 8
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which revealed that CBT is superior to control conditions
(supportive psychotherapy, pharmacotherapy) in MVA
survivors [14,37,38]. The degree of improvement in our
CBT group was comparable to that in previously reported
research trials [10,13] in finding treatment is superior to
Wait List control condition. We acknowledge that other
recently conducted treatment trials in other countries
showed somewhat higher effect sizes for treatment out-
comes [17-19]. These studies differ from the early CBT
studies of PTSD treatment by introducing elaborated cog-
nitive procedures to the treatment.
Our results extend those of the Blanchard and Hickling
treatment study in two ways: the inclusion of advanced
cognitive procedures to our treatment protocol (e.g., cog-
nitive restructuring of guilt and anger, facilitating of post-
traumatic growth) and our population had chronic PTSD
since average interval between trauma and treatment was
five years. Results were corroborated on several psycho-
logical questionnaires, including those related to PTSD,
the IES-R and PTCI, the BDI for measuring depression,
and the STAI for measuring anxiety.
There are several limitations of the current study. First, we
were not able to systematically test if the newly added
treatment techniques contributed to the general result
over and above the CBT standard techniques. Further dis-
mantling should clarify this question. Second, our study
included a relatively large proportion of patients with sub-
threshold PTSD. Inclusion of subthreshold PTSD is partly
justified by the high distress experienced by these cases
[25] and the fact that ICD-10 criteria of PTSD as official
reference for mental disorders definition in Germany has
a lower diagnostic threshold than DSM-IV criteria. Third,
although we applied a matching procedure in our rand-
omization method there remained some initial group dif-
ferences (e.g., gender imbalance, higher CAPS values of
CBT group members) that may have resulted in underes-
timation of treatment success because not all participants
could be matched into pairs according to gender, age and
CAPS score. Furthermore, our random allocation proce-
dure (matched pairs) appeared to have restricted random
assignment slightly. And lastly, we only report short term
(3 months) follow-up data here. This is to be resolved by
reporting a longer-term follow-up in a subsequent paper.
Conclusion
In conclusion, successful treatment procedures of PTSD
are available in different languages. We had translated and
somewhat supplemented a CBT protocol for the purpose
of patients with German mother tongue. Thus, the current
psychotherapy protocol seems suitable for PTSD patients.
Furthermore, as recently discussed by other treatment
researchers, both psychological and biological outcome
measures can uncover more detailed information about
the complexity of treatment response. Consequently, our
research group will publish results of the presented treat-
ment trial on changes in self-perceived posttraumatic
growth [36] and on neurobiological changes initiated the
present treatment protocol [e.g., [33]].
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Table 3: Clinical significance: Categorical diagnostic results for PTSD before and after treatment
Condition Pre-treatment diagnoses Post-treatment diagnoses Follow-up diagnoses
CBT (N = 21) PTSD (N = 12) PTSD (N = 3) PTSD (N = 4)
Sub-PTSD (N = 2) Sub-PTSD (N = 1)
Non-PTSD (N = 7) Non-PTSD (N = 7)
Sub-PTSD (N = 9) PTSD (N = 0) PTSD (N = 0)
Sub-PTSD (N = 2) Sub-PTSD (N = 0)
Non-PTSD (N = 7) Non-PTSD (N = 9)
Wait List (N = 21) PTSD (N = 10) PTSD (N = 6) -
Sub-PTSD (N = 3) -
Non-PTSD (N = 1) -
Sub-PTSD (N = 11) PTSD (N = 2) -
Sub-PTSD (N = 6) -
Non-PTSD (N = 3) -Page 6 of 8
(page number not for citation purposes)
BMC Psychiatry 2006, 6:29 http://www.biomedcentral.com/1471-244X/6/29Acknowledgements
This study was funded by the Deutsche Forschungsgemeinschaft (KA1476/
3). The authors would like to thank Edward B. Blanchard and Edward J. 
Hickling for many helpful suggestions at various stages of our treatment 
study. We would also like to thank our colleagues Anne Boos, Andrea Häh-
nel, and Michael Klose for serving as therapists, and Silvia Lemke, Andreas 
Poldrack, and Frank Schirmer for supervisory activities. Furthermore, we 
thank Kerstin Bader, Denise Dörfel, Dorion Kruska, Robert Langner, 
Susanne Leiberg, Anja Lüdemann, Constanze Nennewitz and Katrin Pöt-
trich for serving as assessors at various stages of the research and for assist-
ing with data entry. We also have to thank Hans-Ulrich Wittchen and 
Jurgen Hoyer for their support with access to treatment facilities at the 
Outpatient unit for Clinical Psychology and Psychotherapy at the University 
of Technology Dresden.
References
1. Statistisches Bundesamt Deutschland: Statistisches Jahrbuch 2005 für
die Bundesrepublik Deutschland Metzler-Poeschel: Stuttgart; 2005. 
2. Breslau N, Peterson EL, Poisson LM, Schultz LR, Lucia VC: Estimat-
ing post-traumatic stress disorder in the community: life-
time perspective and the impact of typical traumatic events.
Psychol Med 2004, 34:889-898.
3. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB: Post-trau-
matic stress disorder in the National Comorbidity Survey.
Arch Gen Psychiat 1995, 52:1048-1060.
4. Maercker A, Michael T, Fehm E, Becker ES, Margraf J: Age of trau-
matisation as a predictor of post-traumatic stress disorder
or major depression in young woman.  Br J Psychiatry 2004,
184:482-487.
5. Perkonigg A, Kessler RC, Storz S, Wittchen HU: Traumatic events
and post-traumatic stress disorder in the community: prev-
alence, risk factors and comorbidity.  Acta Psychiat Scand 2000,
101:46-59.
6. Schnyder U, Moergeli H, Klaghofer R, Buddeberg C: Incidence and
prediction of posttraumatic stress disorder symptoms in
severely injured accident victims.  Am J Psychiat 2001,
158:594-599.
7. Frommberger UH, Stieglitz RD, Nyberg E, Schlickwei W, Kuner E,
Berger M: Prediction of posttraumatic stress disorder by
immediate reactions to trauma: a prospective study in road
traffic accident victims.  Europ Archiv Psychiat Clin Neuroscience
1998, 248:316-321.
8. Blanchard EB, Hickling EJ: After the crash: Assessment and treatment of
motor vehicle accident survivors 2nd edition. American Psychological
Association: Washington; 2003. 
9. Brunello N, Davidson JR, Deahl M, Kessler RC, Mendlewicz J, Racagni
G, Shalev AY, Zohar J: Posttraumatic stress disorder: diagnosis
and epidemiology, comorbidity and social consequences,
biology and treatment.  Neuropsychobiol 2001, 43:150-162.
10. Bisson J, Andrew M: Psychological treatment of post-traumatic
stress disorder.  Cochrane Library 2005, 2:1-61.
11. Bradley R, Greene J, Russ E, Dutra L, Westen D: A multidimen-
sional meta-analysis of psychotherapy for PTSD.  Am J Psychiat
2005, 162:214-227.
12. Foa EB, Keane TM, Friedman MJ, eds: Effective treatments for PTSD
Guilford Press: New York; 2000. 
13. van Etten ML, Taylor S: Comparative efficacy of treatments for
posttraumatic stress disorder: A meta-analysis.  Clin Psychol
Psychother 1998, 5:126-144.
14. Blanchard EB, Hickling EJ, Devineni T, Veazy CH, Galovski TE, Mundy
E, Malta LS, Buckley TC: A controlled evaluation of cognitiive
behavioral therapy for posttraumatic stress in motor vehicle
accident survivors.  Behav Res Ther 2003, 41:79-96.
15. Blanchard EB, Hickling EJ, Malta LS, Freidenberg BM, Canna MA, Kuhn
E, Sykes MA, Galovski TE: One- and two-year prospective fol-
low-up of cognitive behaior therapy or supportive psycho-
therapy.  Behav Res Ther 2004, 42:745-759.
16. Foa EB, Rothbaum BO, Maercker A: Posttraumatische Belas-
tungsstörungen.  In Lehrbuch der Verhaltenstherapie [Textbook of
behavioral therapy] 2nd edition. Edited by: Jürgen Margraf. Springer:
Berlin; 1999:107-122. 
17. Bryant RA, Moulds ML, Guthrie RM, Dang ST, Nixon RDV: Imaginal
exposure alone and imaginal exposure with cognitive
restructuring in the treatment of posttraumatic stress disor-
der.  Journ Consult Clin Psychol 2003, 71:706-712.
18. Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M: Cognitive
therapy for PTSD: development and evaluation.  Behav Res
Therap 2005, 43:413-431.
Table 4: Psychological test results for all groups at pre-treatment, post-treatment and 3-months follow up
Measure Groups Group × Pre-Post F value, 
effect size
ANCOVA post tests between groups with 
pretests as covariates/effect size
Time CBT Wait List
IESR-Intrusion Pre 21.7a 20.0a F = 28.5, p < 0.001 F = 28.8, p < 0.001,
Post 7.6b 17.6a d = 1.89 d = 1.74
FU 8.8b -
IESR-Avoidance Pre 19.0a 16.5a F = 10.7, p < 0.01 F = 10.4, p < 0.01
Post 10.7a 16.6a d = 1.16 d = 1.05
FU 8.8a -
IESR-Hyperarousal Pre 20.1a 20.7a F = 11.9 p < 0.001 F = 8.9, p < 0.01
Post 9.6b 16.6a d = 1.22 d = 0.97
FU 9.2b -
BDI Pre 17.9a 16.0a F = 4.9 p < 0.05 F = 6.6, p = 0.14
Post 9.1b 12.6a d = 0.78 d = 0.83
FU 10.0b -
STAI Pre 50.5a 49.1a F = 6.4 p < 0.01 F = 6.5, p < 0.01
Post 40.9a 46.2a d = 0.89 d = 0.83
FU 41.9a -
PTCI Pre 123.3a 107.9a F = 20.2 p < 0.001 F = 16.7, p < 0.001
Post 86.1b 100.25a d = 1.59 d = 1.33
FU 92.5b -
a, b, c Means within a column which share a superscript do not differ at p = 0.05Page 7 of 8
(page number not for citation purposes)
BMC Psychiatry 2006, 6:29 http://www.biomedcentral.com/1471-244X/6/29Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
19. Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M, Herbert C,
Mayou R: A randomized controlled trial of cognitive therapy,
self-help booklet, and repeated assessment as early interven-
tions for PTSD.  Arch Gen Psychiat 2003, 60:1024-1032.
20. Resick PA, Nishith P, Weaver TL, Astin MC, Feuer CA: A compar-
ison of cognitive processing therapy with prolonged expo-
sure and a waiting condition for the treatment of chronic
posttraumatic stress disorder in female rape victims.  J Consult
Clin Psych 2002, 70:867-879.
21. Lange A, Rietdijk D, Hucovicova M, van de Ven JP, Schrieken B,
Emmelkamp PMG: Interapy: A controlled randomized trial of
the standardized treatment of posttraumatic stress through
the internet.  J Consult Clin Psychol 2003, 71:901-909.
22. Lindauer RJL, Gersons BPR, van Meijel EPM, Blom K, Carlier IVE, Vri-
jlandt I, Olff M: Effects of Brief Eclectic Psychotherapy in
patients with posttraumatic stress disorder: Randomized
clinical trial.  J Traum Stress 2005, 18:202-215.
23. Zöllner T, Maercker A: Posttraumatic growth and psychother-
apy.  In Handbook of posttraumatic growth: research and practice Edited
by: Lawrence Calhoun, Richard Tedeschi. New York: Erlbaum;
2006:334-354. 
24. Zöllner T, Karl A, Maercker A, Blanchard EB, Hickling EJ: Manual zur
Kognitiven Verhaltenstherapie von Posttraumatischen Belastungsstörungen
bei Verkehrsunfallopfern [Manual of cognitive behavioral therapy of PTSD
in MVA victims] Lengerich: Pabst; 2005. 
25. Schützwohl M, Maercker A: Effects of varying diagnostic criteria
for PTSD.  J Trauma Stress 1999, 12:155-165.
26. Schnyder U, Moergeli H: German version of Clinician-Adminis-
tered PTSD Scale.  J Trauma Stress 2002, 15:487-492.
27. Wittchen HU, Zaudig M, Fydrich T: Strukturiertes Klinisches Interview
für DSM-IV Hogrefe: Göttingen; 1997. 
28. Maercker A, Schützwohl M: Erfassung von psychischen Belas-
tungsfolgen: Die Impact of Event Skala-revidierte Version
(IES-R).  Diagnostica 1998, 44:130-141.
29. Hautzinger M, Bailer M, Worall H, Keller F: Beck-Depressions Inventar
(BDI) Huber: Bern; 1994. 
30. Laux L, Glanzmann P, Schaffner P, Spielberger CD: Das State-Trait-Ang-
stinventar (STAI) Beltz: Weinheim; 1981. 
31. Foa EB, Ehlers A, Clark DM, Tolin DF, Orsillo SM: The Posttrau-
matic Cogntions Inventory (PTCI): Development and valida-
tion.  Psychol Assess 1999, 11:303-314.
32. Ehlers A: Posttraumatische Belastungsstörung [Posttraumatic
stress disorder].  Hogrefe: Göttingen; 1999. 
33. Rabe S, Beauducel B, Zöllner T, Maercker A, Karl A: Regional brain
electrical activity in posttraumatic stress in motor vehicle
accidents victims.  J Abnorm Psychol  in press.
34. Beck AT, Emery G: Cognitive therapy of anxiety and phobic disorders
Center for Cognitive Therapy: Philadelphia; 1979. 
35. Ehlers A, Clark DM: A cognitive model of posttraumatic stress
disorder.  Behav Res Ther 2000, 38:319-345.
36. Zöllner T, Rabe S, Karl A, Maercker A: Posttraumatic growth as outcome
of cognitive-behavioral intervention trial for PTSD Klinik Roseneck Center
for Behavioral Medicine, Prien am Chiemsee, Germany; 2006.  unpub-
lished manuscript
37. Fecteau G, Nicki R: Cognitive behavioural treatment of post
traumatic stress disorder after motor vehicle accident.  Behav
Cognit Psychother 1999, 27:201-214.
38. Frommberger U, Stieglitz RD, Nyberg E, Richter H, Novelli-Fischer U,
Angenendt J, Zaninelli R, Berger M: Comparison between parox-
etine and behaviour therapy in patients with posttraumatic
stress disorder: A pilot study.  Intern J Psychiat Clin Pract 2004,
8:19-23.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-244X/6/29/pre
pubPage 8 of 8
(page number not for citation purposes)
